The Treatment Outcomes of Cesarean Scar Pregnancy

NCT07608094 · tracked via the Priya Life Science China tracker

Sponsor

Women's Hospital School Of Medicine Zhejiang University

Phase

Observational

Started

2025-08-13

Last updated

2026-06-22

Condition(s) studied

Cesarean Scar Pregnancy

Investigational drug(s) / intervention(s)

different surgical treatment

different surgical treatment: The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach. Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.

Study summary

A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes

Eligibility

Sex

FEMALE

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: 1. Women over 18 years old with a history of cesarean section 2. Ultrasound diagnosis of cesarean scar pregnancy 3. No severe internal or external diseases, such as liver disease, kidney disease, cardiovascular disease, cerebrovascular disease, etc., and able to tolerate surgery Exclusion Criteria: 1. Women under the age of 18 2. CSP patients who have received treatment in other hospitals

Primary outcome measure(s)

successful surgical treatment — One day after surgery
successful treatment rate after surgery

Trial sites (1)

Facility	City	Region	Status
Women's Hospital School Of Medicine Zhejiang University	Hangzhou	Zhejiang	Recruiting

More Women's Hospital School Of Medicine Zhejiang University trials in China

Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN Recruiting

Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women Recruiting

Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial Recruiting

Preventive Effect of Probiotics in GDM Recruiting

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07608094 on ClinicalTrials.gov ↗ ← All trials in China